Literature DB >> 15940765

Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.

Colin T Pease1, Glenn Haugeberg, Ann W Morgan, Bridget Montague, Elizabeth M A Hensor, Bipin B Bhakta.   

Abstract

OBJECTIVE: . To examine for demographic and clinical differences between late onset rheumatoid arthritis (LORA), polymyalgia rheumatica (PMR), and temporal arteritis (TA) patients presenting with polymyalgic symptoms (PMS) and to identify baseline clinical and laboratory features that would lead to a more accurate final diagnosis.
METHODS: Three hundred forty-nine consecutive patients with new onset of symptoms suggestive of LORA, PMR, or TA presenting at or above age 60 years were enrolled in a prospective study.
RESULTS: During followup, 9 patients diagnosed initially as PMR developed LORA (giving a final total of 145), 5 patients initially diagnosed as LORA changed diagnosis to PMR (final total 147), and 29 patients had PMS that predated TA symptoms (final total 57). The delay in diagnosis ranged from 1 to 30 months. DRB1*04 was associated with development of both LORA and TA.
CONCLUSION: In about 10% of patients the correct diagnosis of LORA, PMR, and TA in those presenting with PMS may be delayed due to similarities in initial clinical presentation. Longterm followup is essential to establish correct diagnosis. Laboratory tests tend to be unhelpful, although a positive rheumatoid factor or persistently raised plasma viscosity despite steroids might indicate RA, and the presence of HLA-DRB1*04 may indicate underlying RA or TA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940765

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

Review 1.  Giant cell arteritis: diagnosis and therapeutic management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

2.  Coexistence of the monostatic Paget's disease, sensorimotor neuropathy and elderly onset rheumatoid arthritis.

Authors:  Ali Aydeniz; Savaş Gürsoy; Sabri Zincirkeser
Journal:  Rheumatol Int       Date:  2008-10-12       Impact factor: 2.631

3.  Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada.

Authors:  Jean-Pascal Roussy; Louis Bessette; Elham Rahme; Sasha Bernatsky; Jean Légaré; Jean Lachaine
Journal:  Rheumatol Int       Date:  2013-08-20       Impact factor: 2.631

Review 4.  Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.

Authors:  Tanaz A Kermani; Kenneth J Warrington
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

Review 5.  Polymyalgia rheumatica: pathogenesis and management.

Authors:  Sarah Louise Mackie
Journal:  Clin Med (Lond)       Date:  2013-08       Impact factor: 2.659

6.  Cerebral rheumatoid vasculitis: a case report.

Authors:  Rim Akrout; Samar Bendjemaa; Hela Fourati; Mariem Ezzeddine; Imène Hachicha; Chokri Mhiri; Soufiene Baklouti
Journal:  J Med Case Rep       Date:  2012-09-13

7.  Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids.

Authors:  Sarah Louise Mackie; Colin Thomas Pease; Eiji Fukuba; Emma Harris; Paul Emery; Richard Hodgson; Jane Freeston; Dennis McGonagle
Journal:  Ann Rheum Dis       Date:  2015-09-16       Impact factor: 19.103

Review 8.  Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update.

Authors:  Gideon Nesher; Gabriel S Breuer
Journal:  Rambam Maimonides Med J       Date:  2016-10-31

9.  Vascular endothelial growth factor levels and rheumatic diseases of the elderly.

Authors:  Perrine Smets; Valérie Devauchelle-Pensec; Paul-Olivier Rouzaire; Bruno Pereira; Marc Andre; Martin Soubrier
Journal:  Arthritis Res Ther       Date:  2016-12-01       Impact factor: 5.156

Review 10.  Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.

Authors:  James A Prior; Hoda Ranjbar; John Belcher; Sarah L Mackie; Toby Helliwell; Jennifer Liddle; Christian D Mallen
Journal:  BMC Med       Date:  2017-06-28       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.